“Gedatolisib plus Faslodex, with or without Ibrance, represents a potential new standard of care for patients with hormone ...

Piqray plus Faslodex significantly improved PFS in PIK3CA-mutated, hormone receptor-positive, HER2-negative advanced breast ...

Scientists at MIT and Stanford have unveiled a promising new way to help the immune system recognize and attack cancer cells ...

Patients should be selected for treatment with Enhertu in combination with pertuzumab based on confirmed HER2-positive status or HER2 gene amplification (IHC 3+ or ISH+).

The son of one of Connecticut's most famous football families continues to coach while fighting Stage 4 cancer.

Akeega combines niraparib, a PARP inhibitor, and abiraterone acetate, a CYP17 inhibitor, into a single tablet for BRCA2-mutated mCSPC.

Platinum-resistant recurrent epithelial ovarian cancer carries a bleak prognosis, with single-agent chemotherapy yielding ...

When Lucy Turner was diagnosed with an aggressive mouth cancer she was told she would have to terminate her pregnancy.

While the current approval focuses on the second-line setting, research is already moving into earlier stages of the ...

Proton radiotherapy (RT) for oropharyngeal cancer matched conventional photon therapy for slowing disease progression and led ...

Physicians stand to earn big money when signing up patients for drug trials. And lately, some of those trials have been ...

A Birmingham-based doctor has shared the most "unusual" signs of lung cancer, after revealing it has one of the lowest ...